These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 19754797)

  • 1. Evaluation of telomerase-targeted therapies in canine cancer cell lines.
    Argyle DJ; McKevitt T; Gault E; Nasir L
    Vet Comp Oncol; 2004 Dec; 2(4):214-21. PubMed ID: 19379295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapies for B-cell non-Hodgkin lymphoma.
    Briones J
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1305-16. PubMed ID: 19761434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into physiological and pathophysiological functions of cyclo-oxygenase-2.
    Hinz B; Brune K
    Curr Opin Anaesthesiol; 2000 Oct; 13(5):585-90. PubMed ID: 17016362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodegradation mechanism of nonsteroidal anti-inflammatory drugs containing thiophene moieties: suprofen and tiaprofenic acid.
    Musa KA; Eriksson LA
    J Phys Chem B; 2009 Aug; 113(32):11306-13. PubMed ID: 19719267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial and parasitic diseases of selected invertebrates.
    Klaphake E
    Vet Clin North Am Exot Anim Pract; 2009 Sep; 12(3):639-48, Table of Contents. PubMed ID: 19732713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some Aspects Of Newer Treatments Used In Veterinary Practice.
    Maplesden DC
    Can J Comp Med Vet Sci; 1954 Nov; 18(11):401-6. PubMed ID: 17648770
    [No Abstract]   [Full Text] [Related]  

  • 7. 2024 ISFM and AAFP consensus guidelines on the long-term use of NSAIDs in cats.
    Taylor S; Gruen M; KuKanich K; X Lascelles BD; Monteiro BP; Sampietro LR; Robertson S; Steagall PV
    J Feline Med Surg; 2024 Apr; 26(4):1098612X241241951. PubMed ID: 38587872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies.
    Nosalova N; Huniadi M; Horňáková Ľ; Valenčáková A; Horňák S; Nagoos K; Vozar J; Cizkova D
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toceranib phosphate and firocoxib-mediated partial response in a dog with advanced intranasal sarcoma.
    Osada H; Okazawa T; Kushida K; Kishimoto M; Ikeda M; Kondo H; Kimura J; Ohmori K
    J Vet Med Sci; 2023 Sep; 85(9):1004-1009. PubMed ID: 37532540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose meloxicam is safe and tolerable when combined with toceranib phosphate in cancer-bearing cats.
    Keepman SJ; Pellin MA
    J Feline Med Surg; 2022 Dec; 24(12):1187-1194. PubMed ID: 34923878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal non-surgical treatment of a feline tracheal adenocarcinoma.
    Azevedo C; Brawner W; Schleis Lindley S; Smith A
    JFMS Open Rep; 2017; 3(1):2055116916689630. PubMed ID: 28491448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent.
    Annabi B; Lord-Dufour S; Vézina A; Béliveau R
    Drug Target Insights; 2012; 6():1-11. PubMed ID: 22523472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low intracellular ATP levels exacerbate carcinogen-induced inflammatory stress response and inhibit in vitro tubulogenesis in human brain endothelial cells.
    Tahanian E; Peiro S; Annabi B
    J Inflamm Res; 2011; 4():1-10. PubMed ID: 22096365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonoids targeting of IκB phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells.
    Tahanian E; Sanchez LA; Shiao TC; Roy R; Annabi B
    Drug Des Devel Ther; 2011; 5():299-309. PubMed ID: 21625419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer, cyclo-oxygenase and nonsteroidal anti-inflammatory drugs - can we combine all three?
    Hayes A
    Vet Comp Oncol; 2007 Mar; 5(1):1-13. PubMed ID: 19754797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risks and benefits of cyclo-oxygenase-2 inhibitors in prostate cancer: a review.
    Sooriakumaran P; Kaba R
    Int J Surg; 2005; 3(4):278-85. PubMed ID: 17462298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular therapeutics in patients with cancer unresponsive to conventional treatments].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Gac Med Mex; 2008; 144(4):333-44. PubMed ID: 18942268
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.